Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CytRx Corp (NASDAQ:CYTR)

2.78
Delayed Data
As of May 27
 +0.03 / +1.09%
Today’s Change
1.55
Today|||52-Week Range
4.29
+4.91%
Year-to-Date
No recent news for CytRx Corp.

Today’s Trading

Previous close2.75
Today’s open2.75
Day’s range2.68 - 2.80
Volume431,159
Average volume (3 months)760,751
Market cap$183.6M
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-76.36%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,602.80
Price/Book4.15

Competitors

 Today’s
change
Today’s
% change
ENZYEnzymotec Ltd+0.01+0.11%
OVASOvaScience Inc-0.03-0.43%
EVGNEvogene Ltd+0.01+0.15%
OSIROsiris Therapeutics ...+0.08+1.43%
Data as of 4:01pm ET, 05/27/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$100.0K
Annual profit (last year)-$58.6M
Net profit margin-58,587.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Steven A. Kriegsman
Chief Financial Officer &
Treasurer
John Y. Caloz
Corporate headquarters
Los Angeles, California

Forecasts

Partner Offers

Search for Jobs